Learn About Acute Myeloid Leukemia (AML)

View Main Condition: Leukemia

What is the definition of Acute Myeloid Leukemia (AML)?
Acute myeloid leukemia (AML) is a cancer that affects the blood and bone marrow. Conditions are generally called "acute" when they develop quickly and have an aggressive course. The signs and symptoms of AML vary but may include easy bruising; bone pain or tenderness; fatigue; fever; frequent nosebleeds; bleeding from the gums; shortness of breath; and/or weightloss. AML is one of the most common types of leukemia among adults and is rarely diagnosed in people under age 40. There are many potential causes of AML such as certain blood disorders, inherited syndromes, environmental exposures, and drug exposures; however, most people who develop AML have no identifiable risk factor.
Save information for later
Sign Up
Who are the top Acute Myeloid Leukemia (AML) Local Doctors?
TK
Dr. Tapan M. Kadia
Oncology | Hematology Oncology | Hematology
Elite
Highly rated in
41
conditions
Oncology
Hematology Oncology
Hematology

University of Texas System

Physicians Referral Service

1515 Holcombe Blvd, 
Houston, TX 

Tapan Kadia is an Oncologist and a Hematologist Oncology expert in Houston, Texas. Kadia has been practicing medicine for over 22 years and is rated as an Elite expert by MediFind in the treatment of Acute Myeloid Leukemia (AML). He is also highly rated in 41 other conditions, according to our data. His top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration. Kadia is currently accepting new patients.

JL
Dr. Jeffrey E. Lancet
Hematology Oncology | Hematology | Oncology
Elite
Highly rated in
34
conditions
Hematology Oncology
Hematology
Oncology

Moffitt Cancer Center

Moffitt Cancer Center

12902 Usf Magnolia Dr, 
Tampa, FL 

Jeffrey Lancet is a Hematologist Oncology specialist and a Hematologist in Tampa, Florida. Lancet has been practicing medicine for over 31 years and is rated as an Elite expert by MediFind in the treatment of Acute Myeloid Leukemia (AML). He is also highly rated in 34 other conditions, according to our data. His top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration. Lancet is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn more
BP
Dr. Bayard L. Powell
Hematology Oncology | Oncology
Elite
Highly rated in
31
conditions
Hematology Oncology
Oncology

Atrium Health Wake Forest Baptist

Pediatric Hematology Oncology - Ardmore Tower

Medical Center Blvd, 
Winston Salem, NC 

Bayard Powell is a Hematologist Oncology specialist and an Oncologist in Winston Salem, North Carolina. Powell has been practicing medicine for over 43 years and is rated as an Elite expert by MediFind in the treatment of Acute Myeloid Leukemia (AML). He is also highly rated in 31 other conditions, according to our data. His top areas of expertise are Acute Myeloid Leukemia (AML), Acute Promyelocytic Leukemia, Acute Myeloblastic Leukemia with Maturation, Bone Marrow Aspiration, and Bone Marrow Transplant. Powell is currently accepting new patients.

View All Doctors
What are the latest Acute Myeloid Leukemia (AML) Clinical Trials?
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients With Hematologic Malignancies and Other Indications
Enrollment Status: Recruiting
Publish Date: December 15, 2022
Intervention Type: Drug

Summary: This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Parallel Phase II Trial of IPA Targeted Adoptive Immunotherapy vs Adult Haplo-identical Cell Infusion During Induction of High Risk Leukemia
Who is this study for: Patients with high risk leukemia
Enrollment Status: Recruiting
Publish Date: December 15, 2022
Intervention Type: Biological
Study Drugs: Haplo-identical cellsUmbilical cord blood unit
Study Phase: Phase 2

Summary: The purpose of this study is to determine the overall safety of adoptive immunotherapy when given after chemotherapy for AML/MDS. Adoptive immunotherapy means using an infusion of cells from a donor to help fight cancer. The donor cells will be either from the umbilical cord blood (UCB) of a newborn baby or they will be cells collected from a relative (haplo-identical cells). The 2 cohorts that we...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are the Latest Advances for Acute Myeloid Leukemia (AML)?
Chimeric Antigen Receptor T-cell Therapy for Acute Myeloid Leukemia.
Condition: Acute Myeloid Leukemia (AML)
Journal: Hematology/oncology and stem cell therapy
Treatment Used: Chimeric Antigen Receptor (CAR) T-Cell Therapy
Published: December 20, 2022
Clinical Analysis of Salvage Treatment of Glucocorticoid Resistant Graft-Versus-Host Disease with Vedolizumab in Children.
Condition: Glucocorticoid Resistant Graft-Versus-Host Disease (GR-GVHD) in Children
Journal: Zhongguo shi yan xue ye xue za zhi
Treatment Used: Vedolizumab (VDZ)
Number of Patients: 5
Published: December 08, 2022
Tired of the same old research?
Check Latest Advances
SOHO State of the Art Updates and Next Questions |The Role of Maintenance Therapy in Acute Myeloid Leukemia.
Condition: Acute Myeloid Leukemia (AML)
Journal: Clinical lymphoma, myeloma & leukemia
Treatment Used: Maintenance Therapy
Published: December 01, 2022
View All Latest Advances